A detailed history of Squarepoint Ops LLC transactions in Vaxart, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 265,009 shares of VXRT stock, worth $153,705. This represents 0.0% of its overall portfolio holdings.

Number of Shares
265,009
Holding current value
$153,705
% of portfolio
0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.58 - $0.99 $153,705 - $262,358
265,009 New
265,009 $225,000
Q1 2024

May 15, 2024

BUY
$0.56 - $1.41 $92,531 - $232,981
165,235 Added 690.64%
189,160 $245,000
Q4 2023

Feb 14, 2024

BUY
$0.57 - $0.85 $13,637 - $20,336
23,925 New
23,925 $13,000
Q4 2022

Feb 14, 2023

BUY
$0.75 - $2.24 $536,375 - $1.6 Million
715,167 Added 2621.68%
742,446 $712,000
Q3 2022

Nov 14, 2022

BUY
$2.09 - $4.5 $57,013 - $122,755
27,279 New
27,279 $59,000
Q2 2022

Aug 15, 2022

SELL
$2.7 - $5.28 $102,343 - $200,138
-37,905 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$4.29 - $6.64 $103,736 - $160,561
-24,181 Reduced 38.95%
37,905 $191,000
Q4 2021

Feb 14, 2022

SELL
$5.77 - $7.96 $625,156 - $862,434
-108,346 Reduced 63.57%
62,086 $389,000
Q3 2021

Nov 15, 2021

SELL
$6.67 - $9.8 $611,645 - $898,669
-91,701 Reduced 34.98%
170,432 $1.36 Million
Q2 2021

Aug 16, 2021

BUY
$5.06 - $10.78 $179,513 - $382,442
35,477 Added 15.65%
262,133 $1.96 Million
Q1 2021

May 17, 2021

BUY
$5.64 - $23.33 $623,925 - $2.58 Million
110,625 Added 95.34%
226,656 $1.37 Million
Q4 2020

Feb 16, 2021

BUY
$3.5 - $7.98 $406,108 - $925,927
116,031 New
116,031 $663,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $73.4M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.